semaglutide cancer risk GLP-1 drugs and cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up to 50% less likely Can GLP-1 Drugs Reduce Cancer

Animal models and the Phase 2 human trial both showed meaningful reductions in liver fat, a finding relevant for patients with metabolic-associated steatotic liver disease (MASLD)

Suboptimal dosing : Patients may be on a dose intended for diabetes management (0.5-1.0 mg weekly) rather than the higher dose approved for weight loss (2.4 mg weekly)

These variants do not predict exact medication response but may provide context for why some individuals show different baseline weight, glucose metabolism, or appetite regulation patterns

however, current research, as noted by Werkman and colleagues, indicates that GLP-1s may help reduce the risk of lower extremity amputation in patients with type 2 diabetes

May contain: soya, milk, celery and mustard